{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:18:27Z","timestamp":1791429507770,"version":"4.3.3"},"reference-count":32,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["71904005"],"award-info":[{"award-number":["71904005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Project of the National Social Science Fund of China","award":["21&ZD187"],"award-info":[{"award-number":["21&ZD187"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,11,9]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Although the herpes zoster vaccine has been available in mainland China since June 2020, residents\u2019 knowledge of herpes zoster and the herpes zoster vaccine is poor, and vaccination rates are low, especially among the elderly, who are at high risk for herpes zoster. This study assessed willingness to be vaccinated against herpes zoster and factors associated with vaccination among urban residents in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A mixed-methods study was conducted in community health centres from August 2022 to September 2022. We used convenience sampling to select 2864 residents from 9 Chinese cities for the quantitative study and 67 adults for the qualitative study. A structured questionnaire was used for the quantitative study, and data were collected through face-to-face interviews. Multinomial logistic regression was used to analyse factors associated with willingness to vaccinate. Qualitative data were analysed using thematic analysis of barriers to herpes zoster vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 2864 eligible respondents were included in the study. Of these, 42.67% intended to receive the herpes zoster vaccine, 21.44% refused and 35.89% were hesitant. The results of the quantitative and qualitative analyses showed that the factors associated with respondents\u2019 willingness to be vaccinated against herpes zoster included: personal characteristics such as gender, age and income; knowledge and attitudes about herpes zoster and the vaccine; vaccine characteristics such as efficacy, safety and price; and other factors such as pain tolerance and accessibility to vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The low willingness to vaccinate, especially among the elderly, is mainly related to their poor knowledge and negative attitude towards the infection and vaccination. Therefore, health education about herpes zoster, immunisation promotion, and improvement of accessibility and affordability would be valuable in China.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-079115","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T19:17:57Z","timestamp":1701976677000},"page":"e079115","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Willingness to vaccinate against herpes zoster in Chinese urban population: a mixed-methods study"],"prefix":"10.1136","volume":"13","author":[{"given":"Ming","family":"Wang","sequence":"first","affiliation":[{"name":"Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1734-294X","authenticated-orcid":false,"given":"Mingzheng","family":"Hu","sequence":"additional","affiliation":[{"name":"Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6110-6296","authenticated-orcid":false,"given":"Yanshang","family":"Wang","sequence":"additional","affiliation":[{"name":"Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7611-0265","authenticated-orcid":false,"given":"Chao","family":"Long","sequence":"additional","affiliation":[{"name":"Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Xia","sequence":"additional","affiliation":[{"name":"Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiying","family":"Zhao","sequence":"additional","affiliation":[{"name":"Shaoxing University, Shaoxing, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Yuan","sequence":"additional","affiliation":[{"name":"Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5040-5012","authenticated-orcid":false,"given":"Ping","family":"He","sequence":"additional","affiliation":[{"name":"Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"2025121515300666000_13.12.e079115.1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40259-016-0180-7","article-title":"Shingles (herpes zoster) vaccine (Zostavax(\u00ae)): a review in the prevention of herpes zoster and postherpetic neuralgia","volume":"30","author":"Keating","year":"2016","journal-title":"BioDrugs"},{"key":"2025121515300666000_13.12.e079115.2","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-013-0374-z","article-title":"The variegate neurological manifestations of Varicella Zoster virus infection","volume":"13","author":"Gilden","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2025121515300666000_13.12.e079115.3","doi-asserted-by":"crossref","first-page":"e3210","DOI":"10.1093\/cid\/ciaa1185","article-title":"Herpes zoster and postherpetic neuralgia: changing incidence rates from 1994 to 2018 in the United States","volume":"73","author":"Thompson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025121515300666000_13.12.e079115.4","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_1021_16"},{"key":"2025121515300666000_13.12.e079115.5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a3516e"},{"key":"2025121515300666000_13.12.e079115.6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"2025121515300666000_13.12.e079115.7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jinf.2020.12.013","article-title":"Incidence and disease burden of herpes zoster in the population aged \u226550 years in China: data from an integrated health care network","volume":"82","author":"Sun","year":"2021","journal-title":"J Infect"},{"key":"2025121515300666000_13.12.e079115.8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/j.pain.0000000000001718","article-title":"Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition","volume":"161","author":"Harvey","year":"2020","journal-title":"Pain"},{"key":"2025121515300666000_13.12.e079115.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152660","article-title":"Disease burden due to herpes zoster among population aged \u226550 years old in China: a community based retrospective survey","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"2025121515300666000_13.12.e079115.10","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/S2468-2667(17)30234-7","article-title":"Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study","volume":"3","author":"Amirthalingam","year":"2018","journal-title":"Lancet Public Health"},{"key":"2025121515300666000_13.12.e079115.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001420","article-title":"Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study","volume":"10","author":"Langan","year":"2013","journal-title":"PLoS Med"},{"key":"2025121515300666000_13.12.e079115.12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40273-018-0735-1","article-title":"Cost-effectiveness of herpes zoster vaccination: a systematic review","volume":"37","author":"Chiyaka","year":"2019","journal-title":"Pharmacoeconomics"},{"key":"2025121515300666000_13.12.e079115.13","doi-asserted-by":"crossref","DOI":"10.1177\/25151355221084535","article-title":"Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review","volume":"10","author":"Pan","year":"2022","journal-title":"Ther Adv Vaccines Immunother"},{"key":"2025121515300666000_13.12.e079115.14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/14787210.2020.1792290","article-title":"A systematic literature review to assess the burden of herpes zoster disease in China","volume":"19","author":"Yin","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025121515300666000_13.12.e079115.15","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1080\/21645515.2021.1960137","article-title":"Low willingness to vaccinate against herpes zoster in a Chinese metropolis","volume":"17","author":"Lu","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"2025121515300666000_13.12.e079115.16","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1186\/s12879-022-07840-2","article-title":"Willingness to accept herpes zoster vaccines and the influencing factors in China","volume":"22","author":"Jiang","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2025121515300666000_13.12.e079115.17","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.amepre.2016.08.029","article-title":"Herpes zoster vaccine coverage in older adults in the U.S., 2007-2013","volume":"52","author":"Zhang","year":"2017","journal-title":"Am J Prev Med"},{"key":"2025121515300666000_13.12.e079115.18","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-14-1098","article-title":"Herpes zoster vaccine (Hzv): utilization and coverage 2009 \u2013 2013, Alberta, Canada","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Public Health"},{"key":"2025121515300666000_13.12.e079115.19","unstructured":"Creswell JW . A Concise Introduction to Mixed Methods Research. SAGE publications, 2014."},{"key":"2025121515300666000_13.12.e079115.20","unstructured":"Creswell JW , Clark VLP . Designing and Conducting Mixed Methods Research. Sage publications, 2017."},{"key":"2025121515300666000_13.12.e079115.21","unstructured":"Patton MQ . Qualitative Evaluation and Research Methods. SAGE Publications, inc, 1990."},{"key":"2025121515300666000_13.12.e079115.22","first-page":"365","article-title":"A cross-sectional study of the knowledge, attitude, and practice of patients aged 50 years or above towards herpes zoster in an out-patient setting","volume":"23","author":"Lam","year":"2017","journal-title":"Hong Kong Med J"},{"key":"2025121515300666000_13.12.e079115.23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208601","article-title":"Beyond confidence: development of a measure assessing the 5c psychological antecedents of vaccination","volume":"13","author":"Betsch","year":"2018","journal-title":"PLoS One"},{"key":"2025121515300666000_13.12.e079115.24","first-page":"307","article-title":"Willingness to receive herpes Zoster vaccine and factors influencing willingness Among\u2265 50-year-old adults of Shanghai in May-June 2020","volume":"27","author":"Qiu","year":"2020","journal-title":"Chin J Vaccines Immunization"},{"key":"2025121515300666000_13.12.e079115.25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/geronb\/gbab074","article-title":"Social determinants of shingles vaccination in the United States","volume":"77","author":"Vogelsang","year":"2022","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"2025121515300666000_13.12.e079115.26","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-10-333","article-title":"Compliance with herpes zoster vaccination in young and adult individuals in two regions of Italy","volume":"10","author":"Parlato","year":"2010","journal-title":"BMC Public Health"},{"key":"2025121515300666000_13.12.e079115.27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s40121-019-00269-2","article-title":"A community-based survey to assess knowledge, attitudes, beliefs and practices regarding herpes zoster in an urban setting","volume":"8","author":"Baalbaki","year":"2019","journal-title":"Infect Dis Ther"},{"key":"2025121515300666000_13.12.e079115.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k4029","article-title":"Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis","volume":"363","author":"Tricco","year":"2018","journal-title":"BMJ"},{"key":"2025121515300666000_13.12.e079115.29","doi-asserted-by":"publisher","DOI":"10.1159\/000240046"},{"key":"2025121515300666000_13.12.e079115.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.10.047"},{"key":"2025121515300666000_13.12.e079115.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.11.077"},{"key":"2025121515300666000_13.12.e079115.32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011539","article-title":"Evaluation of the acceptability of a vaccine against herpes zoster in the over 50\u2005years old: an Italian observational study","volume":"6","author":"Valente","year":"2016","journal-title":"BMJ Open"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-079115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T23:30:15Z","timestamp":1765841415000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-079115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,7]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/bmjopen-2023-079115"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-079115","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}